Ig-like transcript 3 regulates expression of proinflammatory cytokines and migration of activated T cells

Journal of Immunology

Volumn 182, Issue 9, 2009, Pages 5208-5216

  Chang, Chih Chao ^a   Liu, Zhuoru ^a   Vlad, George ^a   Qin, Haiyan ^a   Qiao, Xugang ^a   Mancini, Donna M ^a   Marboe, Charles C ^a   Cortesini, Raffaello ^a   Suciu Foca, Nicole ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL11 CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 3; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN; PROTEIN ILT3; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN; AUTACOID; IMMUNOGLOBULIN RECEPTOR; LEUKOCYTE ANTIGEN; LILRB3 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; DENDRITIC CELL; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; KNOCKOUT GENE; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; BIOSYNTHESIS; CELL CULTURE; CELL LINE; CYTOLOGY; DRUG ANTAGONISM; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; NEUTROPHIL CHEMOTAXIS; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD; CELL LINE; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; HUMANS; INFLAMMATION MEDIATORS; LYMPHOCYTE ACTIVATION; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTE SUBSETS;

EID: 66949121459     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0804048     Document Type: Article

References (38)

1. Cella, M., C. Dohring, J. Samaridis, M. Dessing, M. Brockhaus, A. Lanzavecchia, and M. Colonna. 1997. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J. Exp. Med. 185: 1743-1751. (Pubitemid 27242195)
2. Brown, D., J. Trowsdale, and R. Allen. 2004. The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens 64: 215-225. (Pubitemid 39120446)
3. + tolerogenic endothelial cells, inhibiting alloreactivity. Int. Immunol. 16: 1055-1068.
4. Chang, C. C., R. Ciubotariu, J. S. Manavalan, J. Yuan, A. I. Colovai, F. Piazza, S. Lederman, M. Colonna, R. Cortesini, R. Dalla-Favera, and N. Suciu-Foca. 2002. Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 3: 237-243.
5. + suppressor and cytotoxic T cells recognize the same human leukocyte antigen-A2 restricted cytomegalovirus peptide. Hum. Immunol. 69: 776-780.
6. Suciu-Foca, N., N. Feirt, Q. Y. Zhang, G. Vlad, Z. Liu, H. Lin, C. C. Chang, E. K. Ho, A. I. Colovai, H. Kaufman, et al. 2007. Soluble Ig-like transcript 3 inhibits tumor allograft rejection in humanized SCID mice and T cell responses in cancer patients. J. Immunol. 178: 7432-7441. (Pubitemid 46847471)
7. + T suppressor cells. J. Immunol. 176: 2790-2798.
8. Vlad, G., V. D. D'Agati, Q. Y. Zhang, Z. Liu, E. K. Ho, T. Mohanakumar, M. A. Hardy, R. Cortesini, and N. Suciu-Foca. 2008. Immunoglobulin-like transcript 3-Fc suppresses T cell responses to allogeneic human islet transplants in hu-NOD/SCID mice. Diabetes 57: 1878-1886.
9. + regulatory T cells by 1,25-dihydroxyvitamin D3. Blood 106: 3490-3497.
10. Manavalan, J. S., P. C. Rossi, G. Vlad, F. Piazza, A. Yarilina, R. Cortesini, D. Mancini, and N. Suciu-Foca. 2003. High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transpl. Immunol. 11: 245-258.
11. Raetz, C. R., and C. Whitfield. 2002. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71: 635-700.
12. Beutler, B. 2004. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430: 257-263. (Pubitemid 38902439)
13. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801.
14. Hoffmann, A., G. Natoli, and G. Ghosh. 2006. Transcriptional regulation via the NF-κB signaling module. Oncogene 25: 6706-6716. (Pubitemid 44657847)
15. Perkins, N. D. 2006. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene 25: 6717-6730. (Pubitemid 44657848)
16. Scheidereit, C. 2006. IκB kinase complexes: gateways to NF-κB activation and transcription. Oncogene 25: 6685-6705. (Pubitemid 44657846)
17. Bruhns, P., F. Vely, O. Malbec, W. H. Fridman, E. Vivier, and M. Daeron. 2000. Molecular basis of the recruitment of the SH2 domain-containing inositol 5-phosphatases SHIP1 and SHIP2 by fcγRIIB. J. Biol. Chem. 275: 37357-37364. (Pubitemid 32004838)
18. Isnardi, I., R. Lesourne, P. Bruhns, W. H. Fridman, J. C. Cambier, and M. Daeron. 2004. Two distinct tyrosine-based motifs enable the inhibitory receptor FcγRIIB to cooperatively recruit the inositol phosphatases SHIP1/2 and the adapters Grb2/Grap. J. Biol. Chem. 279: 51931-51938. (Pubitemid 39656561)
19. Suciu-Foca, N., and R. Cortesini. 2007. Central role of ILT3 in the T suppressor cell cascade. Cell. Immunol. 248: 59-67. (Pubitemid 350101459)
20. Beutler, B. 2009. Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases. Immunol. Rev. 227: 248-263.
21. Gay, N. J., M. Gangloff, and A. N. Weber. 2006. Toll-like receptors as molecular switches. Nat. Rev. Immunol. 6: 693-698.
22. Leulier, F., and B. Lemaitre. 2008. Toll-like receptors - taking an evolutionary approach. Nat. Rev. Genet. 9: 165-178. (Pubitemid 351271799)
23. An, H., J. Hou, J. Zhou, W. Zhao, H. Xu, Y. Zheng, Y. Yu, S. Liu, and X. Cao. 2008. Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1. Nat. Immunol. 9: 542-550. (Pubitemid 351560523)
24. Forget, G., D. J. Gregory, L. A. Whitcombe, and M. Olivier. 2006. Role of host protein tyrosine phosphatase SHP-1 in Leishmania donovani-induced inhibition of nitric oxide production. Infect. Immun. 74: 6272-6279. (Pubitemid 44657407)
25. Zhao, J., D. M. Brooks, and D. I. Lurie. 2006. Lipopolysaccharide- activated SHP-1-deficient motheaten microglia release increased nitric oxide, TNF-α, and IL-1β. Glia 53: 304-312. (Pubitemid 43221351)
26. Sly, L. M., M. J. Hamilton, E. Kuroda, V. W. Ho, F. L. Antignano, S. L. Omeis, C. J. van Netten-Thomas, D. Wong, H. K. Brugger, O. Williams, et al. 2009. SHIP prevents lipopolysaccharide from triggering an anti-viral response in mice. Blood. Jan 12 DOI 10.1182/blood-2008-06-166082.
27. Thelen, M., and J. V. Stein. 2008. How chemokines invite leukocytes to dance. Nat. Immunol. 9: 953-959.
28. Bromley, S. K., T. R. Mempel, and A. D. Luster. 2008. Orchestrating the orchestrators: chemokines in control of T cell traffic. Nat. Immunol. 9: 970-980.
29. Sorensen, T. L., M. Tani, J. Jensen, V. Pierce, C. Lucchinetti, V. A. Folcik, S. Qin, J. Rottman, F. Sellebjerg, R. M. Strieter, et al. 1999. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 103: 807-815.
30. Frigerio, S., T. Junt, B. Lu, C. Gerard, U. Zumsteg, G. A. Hollander, and L. Piali. 2002. β cells are responsible for CXCR3-mediated T cell infiltration in insulitis. Nat. Med. 8: 1414-1420. (Pubitemid 36024137)
31. Vlad, G., E. K. Ho, E. R. Vasilescu, J. Fan, Z. Liu, J. W. Cai, Z. Jin, E. Burke, M. Deng, M. Cadeiras, et al. 2007. Anti-CD25 treatment and FOXP3-positive regulatory T cells in heart transplantation. Transpl. Immunol. 18: 13-21. (Pubitemid 46924832)
32. Mahabeleshwar, G. H., and G. C. Kundu. 2003. Tyrosine kinase p56lck regulates cell motility and nuclear factor κB-mediated secretion of urokinase type plasminogen activator through tyrosine phosphorylation of IκBα following hypoxia/reoxygenation. J. Biol. Chem. 278: 52598-52612. (Pubitemid 38035857)
33. Ghosh, S., and M. S. Hayden. 2008. New regulators of NF-κB in inflammation. Nat. Rev. Immunol. 8: 837-848.
34. Saccani, S., S. Pantano, and G. Natoli. 2002. p38-Dependent marking of inflammatory genes for increased NF-κB recruitment. Nat. Immunol. 3: 69-75. (Pubitemid 34065620)
35. Adams, S., D. W. O'Neill, D. Nonaka, E. Hardin, L. Chiriboga, K. Siu, C. M. Cruz, A. Angiulli, F. Angiulli, E. Ritter, et al. 2008. Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant. J. Immunol. 181: 776-784.
36. Ahonen, C. L., A. Wasiuk, S. Fuse, M. J. Turk, M. S. Ernstoff, A. A. Suriawinata, J. D. Gorham, R. M. Kedl, E. J. Usherwood, and R. J. Noelle. 2008. Enhanced efficacy and reduced toxicity of multifactorial adjuvants compared with unitary adjuvants as cancer vaccines. Blood 111: 3116-3125.
37. Zheng, R., P. A. Cohen, C. A. Paustian, T. D. Johnson, W. T. Lee, S. Shu, and G. K. Koski. 2008. Paired Toll-like receptor agonists enhance vaccine therapy through induction of interleukin-12. Cancer Res. 68: 4045-4049.
38. Kirkwood, J. M., A. A. Tarhini, M. C. Panelli, S. J. Moschos, H. M. Zarour, L. H. Butterfield, and H. J. Gogas. 2008. Next generation of immunotherapy for melanoma. J. Clin. Oncol. 26: 3445-3455.